MIR21 is an oncogenic microRNA implicated in various cellular processes, including wound healing and cancer pathogenesis [PMC7053209, PMC5863695].'>PMC5863695].. In the context of non-small cell lung cancer (NSCLC), serum MIR21 levels are significantly elevated in patients compared to controls and are associated with advanced TNM stages [PMC4737022]. MIR21, along with CYFRA21-1, has been identified as a potential serum marker for the early diagnosis of NSCLC, with joint detection of these markers enhancing diagnostic efficiency [PMC4737022]. Moreover, MIR21 has been shown to confer resistance to heat shock protein 90 (HSP90) inhibitors in cancer cells by modulating the expression of HSP40 [PMC5863695]. Inhibition of MIR21 can restore sensitivity to HSP90 inhibitors, suggesting its potential as a biomarker for treatment response [PMC5863695]. Additionally, increased MIR21 abundance during oocyte maturation is associated with posttranscriptional regulation of programmed cell death 4 (PDCD4) expression and may affect embryonic development [PMC4833929]. Overall, these findings highlight the multifaceted role of MIR21 in disease processes and its utility as a biomarker for diagnosis and treatment response.
A A A u a
ugucgggUAGCUUAUC GACUG UGUUG cugu ga
|||||||||||||||| ||||| ||||| |||| || u
acagucUGUCGGGUAG CUGAC ACAAC ggua cu
- C - - c
| Disease | Description | Category | PubMed ID |
|---|
| Accession | MIMAT0000076 |
| Description | Homo sapiens hsa-miR-21-5p mature miRNA |
| Sequence | 8 - UAGCUUAUCAGACUGAUGUUGA - 29 |
| Evidence |
experimental
cloned [1-3,6-9], Northern [1,5], Illumina [10] |
| Database links |
|
| Predicted targets |
|
| Accession | MIMAT0004494 |
| Description | Homo sapiens hsa-miR-21-3p mature miRNA |
| Sequence | 46 - CAACACCAGUCGAUGGGCUGU - 66 |
| Evidence |
experimental
cloned [8-9] |
| Database links |
|
| Predicted targets |
|
|